Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Overview
- Gender
- male
- Investor Type
- Investment Partner
David Schenkein is a General Partner at GV and was a CEO at Agios Pharmaceuticals. He attended Wesleyan University and State University of New York Upstate Medical University.
Jobs
Number of Current Jobs
4
David Schenkein has 4 current jobs including
Board Observer at Resilience
,
Board Member at Prime Medicine
and
Member of the Board of Directors at Blueprint Medicines
.
| Organization Name | Title At Company | Start Date | End Date | |
|---|---|---|---|---|
Resilience
|
Board Observer | Nov 1, 2020 | — | Detail |
Prime Medicine
|
Board Member | — | — | Detail |
Blueprint Medicines
|
Member of the Board of Directors | — | — | Detail |
Bluebird Bio
|
Member of the Board of Directors | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
